People · Operator
Named in public records as an officer, director or promoter · active 2020–2025 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Talaris Therapeutics, Inc. | — | Biotechnology | Series D+ | $115.0M | $4.4B | 2020 |
| Gen1E Lifesciences Inc. | — | Biotechnology | Series B | $22.5M | $22.5M | 2025 |
| BenevolentAI | — | Other Technology | Series A | $6.2M | $72.5M | 2022 |
Francois Nader at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Francois Nader on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alan Levy | 1 | 7 |
| Scott Requadt | 1 | 5 |
| Geoff MacKay | 1 | 5 |
| Mark McDade | 1 | 5 |
| Michael Brennan | 1 | 3 |
| Nick Galakatos | 1 | 3 |
| Jean Raby | 1 | 1 |
| Olivier Brandicourt | 1 | 1 |
| Nick Keher | 1 | 1 |
| Susan Liautaud | 1 | 1 |
| Ivan Griffin | 1 | 1 |
| Nigel Shadbolt | 1 | 1 |
| John Orloff | 1 | 1 |
| Jackie Hunter | 1 | 1 |
| Sandip Agarwala | 1 | 1 |
| Suzanne Ildstad | 1 | 1 |
| Ritu Lal | 1 | 1 |
| Noor Kamruddin | 1 | 1 |
| Soujanya Bhumkar | 1 | 1 |
| Dr. Alan Levy | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.